|
 Alzheimer's Support
 Merz - our research for your health. Glutamate is the principal neurotransmitter in the brain.
Alzheimer's Support: learn more about the different forms of diseases, current research, drugs, treatment, therapies and care. Alzheimer's Support is a topic that anyone of us should think about, because when growing old, everyone could be affected. Inform yourself about Alzheimer's Support now! The care for elderly people and their diseases are a topic for our society, whose importance grows each day. That's why we at Merz take Alzheimer's Support very serious, so that we can offer you the best drug for each treatment and therapy you need. Alzheimer's Support and Merz means research for your health. High-quality products and information about Alzheimer's Support can be found on our website. Visit us online and learn everything about Alzheimer's Support from one of Germany's leading health care companies. Our contribution to Alzheimer's Support: read here what we can do for you. Further links: Axura: Information for professionals.>>>
The care for elderly people and their diseases are a topic for our society, whose importance grows each day.
Memantine , Alzheimer's Treatment . Calcium enters into the cell, and through secondary processes, the signal is recognized. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Senile Dementia , Dementia Care . During physiological learning and memory processes, high concentrations of synaptic glutamate are transiently released. If you have questions regarding Memantine, Axura or Namenda, please contact the responsible department. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Alzheimer's Research , Alzheimer . During learning and memory processes (i e transient high glutamate release), memantine - the fast, voltage-dependent NMDA-receptor antagonist - leaves the NMDA receptor for a short time. At the same time, Memantine reduces caregiver time by more than 50 hours a month. At the same time, Memantine reduces caregiver time by more than 50 hours a month. At the same time, Memantine reduces caregiver time by more than 50 hours a month. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Demenzkranke , Verwirrtheit Gedächtnisstörungen Short Term Memory Loss Symptoms Of Alzheimer's Disease . As memantine, in contrast to magnesium, blocks the NMDA receptor in the presence of sustained release of low glutamate concentrations, the influx of calcium is prevented (neuroprotection). Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Alzheimer Erkrankung , Symptoms Of Alzheimer's Alzheimer's Disease Symptoms . Recent results from a Phase III trial show that patients receiving a combination of memantine and donepezil performed significantly better than patients receiving donepezil and placebo. The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Alzheimer's Drug Dementia Symptoms , Hirnleistungsstörungen . A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Demenz Krankheit Alzheimer Behandlung NMDA-Schutz Demenz Früherkennung , Mild Cognitive Impairment Altersdemenz . If you have questions regarding Memantine, Axura or Namenda, please contact the responsible department. Under physiological conditions, the NMDA receptor is blocked by magnesium ions, thereby protecting the neuron against glutamatergic excitotoxicity. In contrast to first generation therapies, Memantine is likely to show neuroprotective effects at concentrations used in the treatment of Alzheimer s disease and to slow down disease progression. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. The safety of the combination therapy was investigated in a postmarketing surveillance study. Alzheimer und Demenz , Glutamate Demenz Behandlung Demenz-Erkrankung . Recent results from a Phase III trial show that patients receiving a combination of memantine and donepezil performed significantly better than patients receiving donepezil and placebo. The safety of the combination therapy was investigated in a postmarketing surveillance study. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Alzheimer's Disease Alzheimer Therapie , Symptoms Of Dementia . There is a continuous influx of calcium into the cell, increasing the calcium pool. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. NMDA-Antagonist Forgetfulness , Glutamat Alzheimer Früherkennung . vaskuläre Demenz , Lewy Body Dementia Demenz Therapie Vascular Dementia . During physiological learning and memory processes, high concentrations of synaptic glutamate are transiently released. Glutamatergic overstimulation results in neuronal damage, a phenomenon that has been termed excitotoxicity. Gedächtnis , Demenz . Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Merz , Multi Infarct Dementia . Alzheimer's Dementia Axura , Vergesslichkeit Antidementiva Alzheimer's Caregiver . Stages Of Alzheimer's Disease , Akatinol Alzheimer's Support Hirnleistungsstörung NMDA-Protection . Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Alzheimer's , Demenzerkrankung Dementia . Memory Loss Pseudodemenz Alzheimer's Care , Dementia Treatment . Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist. Dementia And Alzheimer's Alzheimer Krankheit , Demenzkrank . Alzheimer's Symptoms , Mental Confusion . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. Dementia Medication Literatur , Erkennung Diagnose Studien . Memantine is well tolerated even in long-term therapy. Memantine is well tolerated even in long-term therapy. Medikamentkombinationen , Demenz Medikament . Therapy , Help . Diagnosis , Information Literature . Studies , Combination . Treatment Alzheimer's Therapie Demenz Alzheimer Medikament , Medication Alzheimer's .
 Alzheimer's Support
|
